Open access
Open access
Powered by Google Translator Translator

Daily Archives: September 2, 2022

2022 ACC Expert Consensus | Role of nonstatin therapies for LDL-cholesterol lowering and managing cardiovascular disease risk.

2 Sep, 2022 | 13:17h | UTC

2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee – Journal of the American College of Cardiology

News Release: ACC Issues Guidance to Address New Nonstatin Therapies – American College of Cardiology

Commentary: New on the Scene Nonstatin Drugs: Experts Provide Guidance – TCTMD

 

Commentary on Twitter

 


RCT | Bedaquiline–Pretomanid–Linezolid regimens for drug-resistant tuberculosis.

2 Sep, 2022 | 13:16h | UTC

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Three drug regimen with Linezolid 600 mg tied to better outcomes in drug-resistant TB – Medical Dialogues

 


RCT | Fractional flow reserve or intravascular ultrasonography to guide percutaneous coronary intervention.

2 Sep, 2022 | 13:15h | UTC

Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Fractional Flow Reserve Noninferior to IVUS for Guiding PCI – HealthDay

 


Cohort Studies | Increased consumption of ultra-processed foods linked to increased risk of mortality and cancer.

2 Sep, 2022 | 13:15h | UTC

Study 1: Association of ultra-processed food consumption with colorectal cancer risk among men and women: results from three prospective US cohort studies – The BMJ

Study 2: Joint association of food nutritional profile by Nutri-Score front-of-pack label and ultra-processed food intake with mortality: Moli-sani prospective cohort study – The BMJ

Editorial: The trouble with ultra-processed foods – The BMJ

Commentaries:

Expert reaction to two studies looking at ultra-processed foods and heart disease, bowel cancer and death – Science Media Centre

Ultraprocessed foods linked to cancer and early death, studies find – CNN

New research gives more reasons to eat less-processed food – The Guardian

 


Systematic Review | Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse.

2 Sep, 2022 | 13:08h | UTC

Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse – Cochrane Library

 

Commentary on Twitter

 


JCS 2022 Guideline on management and re-interventional therapy in patients with congenital heart disease in the long-term after the initial repair.

2 Sep, 2022 | 13:10h | UTC

JCS 2022 Guideline on Management and Re-Interventional Therapy in Patients With Congenital Heart Disease Long-Term After Initial Repair – Circulation Journal

 


M-A | Which surgeries are the best choice for chronic pancreatitis.

2 Sep, 2022 | 13:05h | UTC

Which Surgeries Are the Best Choice for Chronic Pancreatitis: A Network Meta-Analysis of Randomized Controlled Trials – Frontiers in Surgery

 


Systematic Review | Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use.

2 Sep, 2022 | 13:07h | UTC

Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use – Cochrane Library

 


Systematic Review | Adverse drug reactions in pediatric onco-hematology

2 Sep, 2022 | 13:05h | UTC

Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review – Frontiers in Pharmacology

 


Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management.

2 Sep, 2022 | 13:02h | UTC

Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management – International Journal of Dermatology

 


3-year outcomes of a RCT | First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma.

2 Sep, 2022 | 13:04h | UTC

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743 – Annals of Oncology

Original Study: Randomized trial: First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma

Related: Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

 


Efficacy and activity of PD-1 blockade in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis with focus on the value of PD-L1 combined positive score

2 Sep, 2022 | 13:03h | UTC

Efficacy and activity of PD-1 blockade in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis with focus on the value of PD-L1 combined positive score – ESMO Open

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.